Core Scientific, Inc. - Common Stock (CORZ)

The cryptocurrency market reeled on September 22, 2025, as a staggering $1.7 billion in leveraged positions were liquidated, triggering a rapid and substantial downturn that wiped tens of billions from the overall market capitalization. This event, characterized by its swiftness and scale, has sent shockwaves through the digital asset

CoreWeave's valuation has tumbled in recent months, and that could put a key acquisition at risk.

The cryptocurrency world has been irrevocably reshaped between the April 2024 Bitcoin halving and September 2025, marking a pivotal era where programmed scarcity met unprecedented institutional demand. This period has seen Bitcoin (BTC) shed its image as a purely speculative asset, evolving into a recognized macro-asset driven by a powerful

CoreWeave stock could more than double in value in the next 12 months as demand for artificial intelligence infrastructure persists.

A big acquisition deal may be at risk.

The digital asset landscape is undergoing a monumental transformation in 2025, as an unprecedented wave of institutional capital sweeps into the cryptocurrency market. At the forefront of this financial revolution are Spot Bitcoin Exchange-Traded Funds (ETFs), which have emerged as the primary conduit for traditional finance to access digital assets,

This high-growth AI stock is growing in the wrong direction.

CoreWeave (NASDAQ: CRWV) shares rose as OpenAI contracts and a $9B Core Scientific deal boosted growth momentum.

2025 is marking a pivotal shift in the technology landscape, as the sector's performance begins to broaden significantly beyond the concentrated gains of the "Magnificent 7" mega-cap stocks – Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT), Alphabet (NASDAQ: GOOGL), Amazon (NASDAQ: AMZN), Nvidia (NASDAQ: NVDA), Meta Platforms (NASDAQ: META), and Tesla (NASDAQ:

CoreWeave is a hot AI stock, but it doesn't have Nvidia's long-term advantages.

The company reported revenue growth exceeding 200% in its most recently completed quarter.

CoreWeave (NASDAQ: CRWV) posted strong Q2 results, with surging revenue & backlog driven by AI demand. Expansion plans may lead to near-term costs.

CoreWeave stock fell amid second quarter revenue growth of over 200%. The revenue beat came in at 12%, smaller than Q1's 15% beat.

CoreWeave reports Q2 earnings Tuesday. The lockup period for CoreWeave stock tied to the company's IPO expires Thursday, earlier than usual.

One of CoreWeave's biggest strategic moves could face major challenges. So why is its stock soaring?

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.